Putting translational science on to a global stage
Language English Country Great Britain, England Media print
Document type Journal Article
Grant support
Z01 HG200319
Intramural NIH HHS - United States
PubMed
27032820
PubMed Central
PMC5378162
DOI
10.1038/nrd.2016.33
PII: nrd.2016.33
Knihovny.cz E-resources
- MeSH
- Biomedical Research organization & administration MeSH
- Global Health trends MeSH
- Therapies, Investigational * MeSH
- Humans MeSH
- International Cooperation * MeSH
- Organizational Innovation MeSH
- Technology Transfer * MeSH
- Translational Research, Biomedical * organization & administration trends MeSH
- Inventions * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Global collaboration in translational science promises to accelerate the discovery, development and dissemination of new medical interventions. Here, we introduce a new international collaboration of translational science organizations and highlight our initial strategy to reduce or remove bottlenecks in translation.
EATRIS ERIC European Infrastructure for Translational Medicine Amsterdam 1081 HZ Netherlands
MRC Technology London WC1H 9LT UK
The Centre for Drug Research and Development Vancouver British Columbia V6T 1Z3 Canada
Therapeutic Innovation Australia Melbourne Victoria 2000 Australia
See more in PubMed
Pammolli F, Magazzini L, Riccaboni M. The productivity crisis in pharmaceutical R&D. Nat Rev Drug Discov. 2011;10:428–438. PubMed
Paul SM, et al. How to improve pharmaceutical R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov. 2010;9:203–214. PubMed
Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotech. 2014;32:40–51. PubMed
Arrowsmith J, Miller P. Trial watch: phase II and phase III attrition rates 2011–2012. Nat Rev Drug Discov. 2013;12:569. PubMed
Bridging the translational innovation gap through good biomarker practice
